Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype-Reference-Cited by-同舟云学术

Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype

Published:2002-09 Issue:9 Volume:13 Page:1438-1446
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Bazan V.,Migliavacca M.,Zanna I.,Tubiolo C.,Grassi N.,Latteri M.A.,La Farina M.,Albanese I.,Dardanoni G.,Salerno S.,Tomasino R.M.,Labianca R.,Gebbia N.,Russo A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/13/9/1438/416109/mdf226.pdf

Reference58 articles.

1. The ras Superfamily of GTPases;Lacal,1993

2. The ras signal transduction pathway;Khosravi-far;Cancer Metastasis Rev,1994

3. Proteins regulating Ras and its relatives;Boguski;Nature,1993

4. C-Ki Ras activation and the biological behaviour of proximal and distal colonic adenocarcinomas;Elnatan;Eur J Cancer,1996

5. The ras gene family and human carcinogenesis;Bos;Mutat Res,1988

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic advances of targeting receptor tyrosine kinases in cancer;Signal Transduction and Targeted Therapy;2024-08-14

2. A Challenging Correlation between Tumor Cellularity and Somatic Variant Allele Fraction in Lung and Colorectal Cancers—Specimens of Low Tumor Percentage Should Be Analyzed with Caution;Biomolecules;2024-01-31

3. Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?;British Journal of Cancer;2024-01-08

4. The Abundance of KRAS and RAS Gene Mutations in Cancer;Methods in Molecular Biology;2024

5. Evaluating distinct KRAS subtypes as potential biomarkers for immune checkpoint inhibitor efficacy in lung adenocarcinoma;Frontiers in Immunology;2023-10-24